ELAN vs PETS vs ZTS vs CHWY

For growth investors, Chewy, Inc.

(CHWY) is the stronger pick with 6. 4% revenue growth year-over-year, versus -17. 2% for PetMed Express, Inc. (PETS). Zoetis Inc. (ZTS) offers the better valuation at 14. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate Elanco Animal Health Incorporated (ELAN) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Zoetis Inc.

(ZTS) is the cheapest at 14. 5x versus Chewy, Inc. at 26. 0x. On forward P/E, Zoetis Inc. is actually cheaper at 12. 4x.

Over the past 5 years, Elanco Animal Health Incorporated (ELAN) delivered a total return of -27.

0%, compared to -82. 1% for PetMed Express, Inc. (PETS). Over 10 years, the gap is even starker: ZTS returned +107. 3% versus PETS's -47. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Chewy, Inc.

(CHWY) is the lower-risk stock at 0. 70β versus Elanco Animal Health Incorporated's 1. 42β — meaning ELAN is approximately 102% more volatile than CHWY relative to the S&P 500. On balance sheet safety, PetMed Express, Inc. (PETS) carries a lower debt/equity ratio of 1% versus 3% for Zoetis Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Chewy, Inc.

(CHWY) is pulling ahead at 6. 4% versus -17. 2% for PetMed Express, Inc. (PETS). On earnings-per-share growth, the picture is similar: Chewy, Inc. grew EPS 893. 4% year-over-year, compared to -169. 1% for Elanco Animal Health Incorporated. Over a 3-year CAGR, CHWY leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Zoetis Inc.

(ZTS) is the more profitable company, earning 28. 2% net margin versus -4. 9% for Elanco Animal Health Incorporated — meaning it keeps 28. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ZTS leads at 38. 0% versus -0. 7% for PETS. At the gross margin level — before operating expenses — ZTS leads at 70. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Zoetis Inc.

(ZTS) trades at 12. 4x forward P/E versus 27. 0x for Chewy, Inc. — 14. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHWY: 76. 3% to $41. 71.

In this comparison, ZTS (2.

3% yield), PETS (0. 4% yield) pay a dividend. ELAN, CHWY do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Zoetis Inc.

(ZTS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 90), 2. 3% yield, +107. 3% 10Y return). Both have compounded well over 10 years (ZTS: +107. 3%, ELAN: -33. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ELAN (Healthcare) and PETS (Healthcare) and ZTS (Healthcare) and CHWY (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ELAN is a mid-cap quality compounder stock; PETS is a small-cap quality compounder stock; ZTS is a mid-cap deep-value stock; CHWY is a small-cap quality compounder stock. ZTS pays a dividend while ELAN, PETS, CHWY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.